REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
This purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of bedaquiline (BDQ) in...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
